News - Achillion Pharmaceuticals


Current filters:

Achillion Pharmaceuticals

Popular Filters

Achillion Pharma moves up as a contender in the HCV market, GlobalData believes


On September 27, Achillion Pharmaceuticals (Nasdaq: ACHN) released news of positive results surrounding…

ACH-3102Achillion PharmaceuticalsAnti-viralsBiotechnologyMergers & AcquisitionsPharmaceuticalResearch

US FDA fast-tracks Achillion's hepatitis C drug candidate


USA-based Achillion Pharmaceuticals (Nasdaq: ACHN) says it has received Fast Track designation from the…

Achillion PharmaceuticalsAnti-viralsNorth AmericaPharmaceuticalRegulation

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top